17.4
[1]. Cheng X, et al. MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):25-275.
H302-H315-H31-H335
P21-P24-P270-P271-P280-P302+P352-P304+P340-P330-P32+P34-P405-P501